GENE ONLINE|News &
Opinion
Blog

COVID-19
COVID-19 Oral Drug
Cocrystal Pharma Selects Two Lead Antiviral Drug Candidates for its COVID-19 Oral Drug Program
2022-01-30
COVID-19 COVID-19
New Study Suggests Vaccines Protect against Long COVID
2022-01-28
Innovation Nanoparticle
Left, or Right? Orientation of Nanoparticles Influences Immune Response and Maturation
2022-01-25
Trials & Approvals COVID-19
Remdesivir Cleared for Treating Non-Hospitalized COVID-19 Patients
2022-01-24
China COVID-19
Shanghai’s Everest Medicines Licenses COVID-19 Oral Antivirals from Singapore’s National Drug Discovery Platform
2022-01-17
Partner Digital Healthcare
Digital Health Programme to Connect British and Taiwanese Leaders
2022-01-17Partner
COVID-19 Vaccine
Pfizer: Pneumonia Shot Can Be Given with COVID-19 Vaccine in Older Adults
2022-01-16
Asia-Pacific COVID-19
Concerns Remain as Kintor Pharma’s Proxalutamide Shows Unbelievably High Efficacy Against Covid-19 Infections in Phase 3 Trials
2022-01-16
COVID-19 Vaccine
Scientists Work On an Oral Vaccine Booster for COVID-19
2022-01-07
Go Prime Hong Kong
GeneOnline’s Top 10 Hong Kong Biotech IPOs of 2021
2022-01-07
Technology COVID-19 Variant
Celltrion’s New Antibody Is Effective against the Omicron Variant
2022-01-06
COVID-19 COVID-19
AstraZeneca’s Covid-19 Booster and Antibody Cocktail Retains Neutralizing Ability against Omicron
2021-12-27
M&A COVID-19
Quidel to Acquire Ortho Clinical for $6 billion to Diversify Diagnostics Portfolio
2021-12-24
Ranking & Reports
GeneOnline’s Top 10 Editor’s Picks for 2021
2021-12-23
Innovation COVID-19 Vaccine
Quebec-based Medicago Preps its Homegrown Plant-based COVID-19 Vaccine for Canada Approval, Touting Promising Phase 3 Data
2021-12-21
1 … 4 5 6 7 8 … 27
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top